Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 26Colorectal Neoplasms 17Colonic Neoplasms 15Central Nervous System Neoplasms 15Rectal Neoplasms 11Glioblastoma 7Lung Neoplasms 6Kidney Neoplasms 6Gliosarcoma 6Carcinoma, Non-Small-Cell Lung 6Brain Neoplasms 6Astrocytoma 6Ovarian Neoplasms 5Liver Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Ovarian Epithelial 5Sarcoma 4Neoplasm Metastasis 4Melanoma 4Fallopian Tube Neoplasms 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neuroblastoma 3Glioma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2

Interventions

Radiotherapy 2Ifosfamide 2HhAntag691 2Doxorubicin 2tanespimycin 1enasidenib 1alanosine 1Vincristine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Gelclair 1Filgrastim 1Etoposide 1Epirubicin 1Dactinomycin 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Chondrosarcoma × Chemotherapy, Adjuvant × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡